Fed. Cir.

Allergan, Inc. v. Sandoz Inc., No. 11-1619 (Fed. Cir. May 1, 2013)

Errata

Court: U.S. Court of Appeals for the Federal Circuit
Case No.: No. 11-1619
Decided: May 1, 2013
Judge: —
Document: Errata
Length: 1 page

Full Text Analysis Cite this Opinion

Download Opinion (PDF)

United States Court of Appeals

for the Federal Circuit

July 19, 2013

ERRATA

Appeal No. 2011-1619, -1620, -1635, -1639

ALLERGAN, INC.

SANDOZ INC., ALCON LABORATORIES, INC.,

ALCON RESEARCH, LTD., ALCON, INC.,

AND FALCON PHARMACEUTICALS, LTD.

AND

APOTEX INC. AND APOTEX CORP.

AND

WATSON LABORATORIES, INC.

Decided: May 1, 2013

Precedential Opinion

Please make the following changes: On page 4, line 30, change “timolol” to --brimonidine-- and on line 31 change “brimonidine” to --timolol--.

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Allergan, Inc. v. Sandoz Inc., No. 11-1619 (Fed. Cir. May 1, 2013).

govinfo ID: USCOURTS-ca13-11-01619-1
Permalink: https://patentcasewatch.com/opinions/USCOURTS-ca13-11-01619-1

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.

Source: govinfo.gov USCOURTS collection · retrieved July 25, 2026 · Report an error